Korro Bio's market cap is currently ―. The company's EPS TTM is $-63.36; its P/E ratio is -0.83; Korro Bio is scheduled to report earnings on May 16, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ -1.77M	$ 580.00K	$ 593.00K	$ 593.00K	-
Gross Profit	$ -1.77M	$ 580.00K	$ 593.00K	$ 593.00K	$ 593.00K
EBIT	$ -39.50M	$ -11.62M	$ -10.79M	$ -19.23M	$ -17.50M
EBITDA	$ -37.83M	$ -11.24M	$ -10.30M	$ -18.23M	$ -16.83M
Net Income Common Stockholders	$ -39.22M	$ -11.61M	$ -10.80M	$ -19.54M	$ -17.36M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 166.15M	$ 41.72M	$ 46.48M	$ 66.65M	$ 83.10M
Total Assets	$ 221.66M	$ 46.35M	$ 79.38M	$ 101.50M	$ 121.24M
Total Debt	$ 33.21M	$ 1.43M	$ 27.81M	$ 39.97M	$ 42.95M
Net Debt	$ -132.94M	$ -40.30M	$ -18.67M	$ -26.68M	$ -40.15M
Total Liabilities	$ 51.75M	$ 9.61M	$ 33.98M	$ 48.25M	$ 52.04M
Stockholders Equity	$ 169.91M	$ 36.74M	$ 45.41M	$ 53.25M	$ 69.19M
Cash Flow	-
Free Cash Flow	$ -47.66M	$ -4.80M	$ -8.42M	$ -14.23M	$ -15.62M
Operating Cash Flow	$ -39.92M	$ -4.80M	$ -8.42M	$ -14.13M	$ -15.62M
Investing Cash Flow	$ -20.36M	$ 6.82M	$ 19.21M	$ 5.50M	$ 24.56M
Financing Cash Flow	$ 201.89M	$ 2.00K	$ -11.67M	$ -2.47M	$ -833.00K

Currency in USD

Korro Bio Earnings and Revenue History

Income Statement >

Korro Bio Debt to Assets

Balance Sheet >

Korro Bio Cash Flow

Cash Flow >

Korro Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing